PMID- 30319969 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220409 IS - 2234-943X (Print) IS - 2234-943X (Electronic) IS - 2234-943X (Linking) VI - 8 DP - 2018 TI - Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy. PG - 404 LID - 10.3389/fonc.2018.00404 [doi] LID - 404 AB - Dendritic cells (DCs) are the primary antigen-presenting cells and play key roles in the orchestration of the innate and adaptive immune system. Targeting DCs by nanotechnology stands as a promising strategy for cancer immunotherapy. The physicochemical properties of nanoparticles (NPs) influence their interactions with DCs, thus altering the immune outcome of DCs by changing their functions in the processes of maturation, homing, antigen processing and antigen presentation. In this review, we summarize the recent progress in targeting DCs using NPs as a drug delivery carrier in cancer immunotherapy, the recognition of NPs by DCs, and the ways the physicochemical properties of NPs affect DCs' functions. Finally, the molecular pathways in DCs that are affected by NPs are also discussed. FAU - Jia, Jianbo AU - Jia J AD - Key Laboratory for Water Quality and Conservation of the Pearl River Delta, Ministry of Education, Institute of Environmental Research at Greater Bay, Guangzhou University, Guangzhou, China. FAU - Zhang, Yi AU - Zhang Y AD - School of Chemistry and Chemical Engineering, Shandong University, Jinan, China. FAU - Xin, Yan AU - Xin Y AD - School of Chemistry and Chemical Engineering, Shandong University, Jinan, China. FAU - Jiang, Cuijuan AU - Jiang C AD - School of Environmental Science and Engineering, Shandong University, Jinan, China. FAU - Yan, Bing AU - Yan B AD - Key Laboratory for Water Quality and Conservation of the Pearl River Delta, Ministry of Education, Institute of Environmental Research at Greater Bay, Guangzhou University, Guangzhou, China. AD - School of Environmental Science and Engineering, Shandong University, Jinan, China. FAU - Zhai, Shumei AU - Zhai S AD - School of Chemistry and Chemical Engineering, Shandong University, Jinan, China. LA - eng PT - Journal Article PT - Review DEP - 20180925 PL - Switzerland TA - Front Oncol JT - Frontiers in oncology JID - 101568867 PMC - PMC6167641 OTO - NOTNLM OT - DC functions OT - DC targeting OT - cancer immunotherapy OT - nanoparticles OT - physicochemical properties EDAT- 2018/10/16 06:00 MHDA- 2018/10/16 06:01 PMCR- 2018/01/01 CRDT- 2018/10/16 06:00 PHST- 2018/06/28 00:00 [received] PHST- 2018/09/04 00:00 [accepted] PHST- 2018/10/16 06:00 [entrez] PHST- 2018/10/16 06:00 [pubmed] PHST- 2018/10/16 06:01 [medline] PHST- 2018/01/01 00:00 [pmc-release] AID - 10.3389/fonc.2018.00404 [doi] PST - epublish SO - Front Oncol. 2018 Sep 25;8:404. doi: 10.3389/fonc.2018.00404. eCollection 2018.